SEC v. Ruimin Xie

Ruimin Xie allegedly engaged in insider trading in advance of the April 18, 2023 announcement that BELLUS Health Inc. would be acquired by GSK plc. According to the SEC, between April 12 and 17, 2023, Xie purchased 7,051 BELLUS Health shares and 10 short-term, out-of-the-money call options that allowed him to purchase another 1,000 BELLUS Health shares. The SEC alleges that Xie generated ill-gotten gains of $59,408.42.

Summary generated from official Securities and Exchange Commission press release